LORAZEPAM
LORAZEPAM
Discontinued
DIN Number
02351072
Drug Class
Human
Market Date
Jun 15, 2010
Company
HC
sanis health inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02351072
AIG Number0110731003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LORAZEPAMActive
Strength: 0.5 MG
Monograph: LORAZEPAM